Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:NVO NYSE:OGE NASDAQ:OMER NASDAQ:QURE NASDAQ:SDST On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVONovo Nordisk A/S$44.63+0.8%$39.84$35.12▼$81.44$199.18B0.7721.51 million shs4.57 million shsOGEOGE Energy$48.03+1.5%$47.82$41.69▼$50.13$9.92B0.551.63 million shs268,166 shsOMEROmeros$11.76+0.5%$12.27$2.95▼$17.65$849.02M2.661.44 million shs495,335 shsQUREuniQure$24.78-0.6%$18.60$8.73▼$71.50$1.56B0.872.81 million shs391,289 shsSDSTStardust Power$1.99-5.7%$2.64$1.42▼$7.67$19.83M0.56305,680 shs103,246 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVONovo Nordisk A/S-0.87%-4.35%+9.50%-10.10%-31.12%OGEOGE Energy+2.23%-0.25%-1.78%+0.69%+6.65%OMEROmeros-4.49%-18.52%-12.95%-1.93%+264.49%QUREuniQure-7.84%-9.80%+41.81%+14.62%+81.97%SDSTStardust Power-5.80%-11.34%-28.47%-37.20%-69.77%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVONovo Nordisk A/S$44.63+0.8%$39.84$35.12▼$81.44$199.18B0.7721.51 million shs4.57 million shsOGEOGE Energy$48.03+1.5%$47.82$41.69▼$50.13$9.92B0.551.63 million shs268,166 shsOMEROmeros$11.76+0.5%$12.27$2.95▼$17.65$849.02M2.661.44 million shs495,335 shsQUREuniQure$24.78-0.6%$18.60$8.73▼$71.50$1.56B0.872.81 million shs391,289 shsSDSTStardust Power$1.99-5.7%$2.64$1.42▼$7.67$19.83M0.56305,680 shs103,246 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVONovo Nordisk A/S-0.87%-4.35%+9.50%-10.10%-31.12%OGEOGE Energy+2.23%-0.25%-1.78%+0.69%+6.65%OMEROmeros-4.49%-18.52%-12.95%-1.93%+264.49%QUREuniQure-7.84%-9.80%+41.81%+14.62%+81.97%SDSTStardust Power-5.80%-11.34%-28.47%-37.20%-69.77%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNVONovo Nordisk A/S 2.13Hold$65.5646.91% UpsideOGEOGE Energy 2.40Hold$49.112.25% UpsideOMEROmeros 3.00Buy$40.33242.91% UpsideQUREuniQure 2.53Moderate Buy$42.8372.87% UpsideSDSTStardust Power 1.50ReduceN/AN/ACurrent Analyst Ratings BreakdownLatest QURE, NVO, OGE, OMER, and SDST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/14/2026OMEROmeros Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Hold (C-)5/14/2026OMEROmeros HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$40.005/12/2026NVONovo Nordisk A/S CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral5/11/2026OGEOGE Energy LADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$42.50 ➝ $47.005/6/2026QUREuniQure HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$70.00 ➝ $50.005/5/2026QUREuniQure Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$28.005/4/2026OGEOGE Energy Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeBuy (B-) ➝ Buy (B)4/30/2026OGEOGE Energy Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$47.00 ➝ $48.004/30/2026QUREuniQure Chardan CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$31.00 ➝ $37.004/27/2026OGEOGE Energy Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeUnderweight ➝ Equal Weight$42.00 ➝ $47.004/22/2026NVONovo Nordisk A/S Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)(Data available from 5/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNVONovo Nordisk A/S$46.80B4.26$4.68 per share9.54$6.58 per share6.78OGEOGE Energy$3.26B3.04$5.31 per share9.05$24.71 per share1.94OMEROmerosN/AN/A$1.80 per share6.55($1.71) per shareN/AQUREuniQure$16.10M97.07N/AN/A$3.19 per share7.77SDSTStardust PowerN/AN/AN/AN/A($0.59) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNVONovo Nordisk A/S$15.51B$4.2610.4712.973.9837.23%63.31%22.19%8/5/2026 (Estimated)OGEOGE Energy$470.70M$2.2421.4518.543.4314.03%9.47%3.20%7/29/2026 (Estimated)OMEROmeros-$3.35M$0.7016.76N/AN/AN/A-102.16%64.87%N/AQUREuniQure-$198.97M-$3.48N/AN/AN/A-1,154.42%-145.81%-27.15%8/4/2026 (Estimated)SDSTStardust Power-$15.72M-$2.00N/AN/AN/AN/AN/A-161.57%N/ALatest QURE, NVO, OGE, OMER, and SDST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026SDSTStardust Power-$0.39-$0.53-$0.14-$0.53$1.00 millionN/A5/13/2026Q1 2026OMEROmeros-$0.40-$0.24+$0.16$0.62$4.19 million$9.89 million5/6/2026Q1 2026NVONovo Nordisk A/S$0.87$1.04+$0.17$1.69$10.86 billion$10.85 billion5/5/2026Q1 2026QUREuniQure-$0.88-$0.85+$0.03-$0.85$5.21 million$3.56 million4/28/2026Q1 2026OGEOGE Energy$0.24$0.24N/A$0.24$616.02 million$752.60 million3/31/2026Q1 2026NVONovo Nordisk A/SN/A$1.0270N/A$1.69N/A$10.85 billion3/31/2026Q4 2025OMEROmeros-$0.55$3.14+$3.69$0.98$40.15 millionN/A3/25/2026Q4 2025SDSTStardust Power-$0.4550-$0.34+$0.1150-$0.34$0.67 millionN/A3/3/2026Q4 2025QUREuniQure-$0.93-$0.56+$0.37-$0.56$4.84 million$5.57 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthNVONovo Nordisk A/S$1.753.92%+21.74%41.08%N/AOGEOGE Energy$1.703.54%+1.48%75.89%18 YearsOMEROmerosN/AN/AN/AN/AN/AQUREuniQureN/AN/AN/AN/AN/ASDSTStardust PowerN/AN/AN/AN/AN/ALatest QURE, NVO, OGE, OMER, and SDST DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/14/2026OGEOGE Energyquarterly$0.42503.58%7/6/20267/6/20267/31/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNVONovo Nordisk A/S0.590.790.56OGEOGE Energy1.090.660.40OMEROmerosN/A3.033.03QUREuniQure0.3310.4010.40SDSTStardust PowerN/A0.120.12Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNVONovo Nordisk A/S11.54%OGEOGE Energy71.84%OMEROmeros48.79%QUREuniQure78.83%SDSTStardust Power32.79%Insider OwnershipCompanyInsider OwnershipNVONovo Nordisk A/S0.07%OGEOGE Energy0.57%OMEROmeros12.90%QUREuniQure4.79%SDSTStardust Power55.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNVONovo Nordisk A/S69,5054.47 billion4.46 billionOptionableOGEOGE Energy2,248206.37 million205.20 millionOptionableOMEROmeros21072.38 million63.04 millionOptionableQUREuniQure50063.07 million60.05 millionOptionableSDSTStardust PowerN/A9.97 million4.46 millionN/AQURE, NVO, OGE, OMER, and SDST HeadlinesRecent News About These CompaniesStardust Power (NASDAQ:SDST) Stock Rating Lowered by Wall Street ZenMay 16 at 2:26 AM | americanbankingnews.comStardust Power Inc (SDST) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial ...May 15, 2026 | finance.yahoo.comStardust Power Inc. (SDST) Q1 2026 Earnings Call Prepared Remarks TranscriptMay 14, 2026 | seekingalpha.comStardust Power Announces Q1 2026 Financial ResultsMay 14, 2026 | globenewswire.comStardust Power (SDST) Projected to Post Quarterly Earnings on ThursdayMay 12, 2026 | americanbankingnews.comStardust Power (SDST) Secures a $150 Million Framework for Its Oklahoma Lithium RefineryMay 8, 2026 | insidermonkey.comStardust Power Announces Q1 2026 Earnings Release Date, Conference CallMay 7, 2026 | globenewswire.comStardust Power Receives Nasdaq Noncompliance Delisting NoticeApril 30, 2026 | tipranks.comStardust Power Secures Institutional Investment Framework Supporting Up to $150 Million InvestmentApril 22, 2026 | markets.businessinsider.comStardust Power Secures Major Lithium Refinery Financing FrameworkApril 20, 2026 | tipranks.comStardust Power Inc. Signs Letter of Intent for $150 Million Project-Level Financing for Lithium Refinery in OklahomaApril 20, 2026 | quiverquant.comQStardust Power Inc. Secures Letter of Intent for Up to $150 Million Project Financing for Lithium Refinery in OklahomaApril 20, 2026 | quiverquant.comQStardust Power expands US lithium supply pipeline for Oklahoma refineryApril 14, 2026 | mining.comStardust Power Expands U.S. Lithium Feedstock Pipeline for Muskogee RefineryApril 13, 2026 | markets.businessinsider.comStardust Power Signs LOI for Lithium SupplyApril 13, 2026 | tipranks.comStardust Power (SDST) price target decreased by 20.00% to 20.40April 9, 2026 | msn.comAnalysts Conflicted on These Industrial Goods Names: Delta Air Lines (DAL) and Stardust Power (SDST)April 1, 2026 | theglobeandmail.comStardust Power Joins Lithium Regional Innovation Cluster to Strengthen American Lithium Supply ChainApril 1, 2026 | markets.businessinsider.comStardust Power (SDST) price target increased by 27.12% to 25.50March 27, 2026 | msn.comStardust Power (NASDAQ:SDST) CFO Sells $10,411.17 in StockMarch 26, 2026 | insidertrades.comMade in the USA: Stardust Power’s 18% Breakout...January 21, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?By Thomas Hughes | April 29, 2026Aeluma’s Market Is Laser-Focused on Fresh Highs—Here’s WhyBy Thomas Hughes | April 20, 2026What the FDA's Latest Proposal Means for Lilly, Novo, and HimsBy Leo Miller | May 7, 2026Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusBy Jessica Mitacek | May 8, 2026Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It PermanentBy Nathan Reiff | May 1, 2026QURE, NVO, OGE, OMER, and SDST Company DescriptionsNovo Nordisk A/S NYSE:NVO$44.63 +0.35 (+0.79%) As of 12:45 PM Eastern This is a fair market value price provided by Massive. Learn more.Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.OGE Energy NYSE:OGE$48.03 +0.72 (+1.52%) As of 12:45 PM Eastern This is a fair market value price provided by Massive. Learn more.OGE Energy Corp., together with its subsidiaries, operates as an energy services provider in the United States. The company generates, transmits, distributes, and sells electric energy. In addition, it provides retail electric service to approximately 896,000 customers, which covers a service area of approximately 30,000 square miles in Oklahoma and western Arkansas; and owns and operates coal-fired, natural gas-fired, wind-powered, and solar-powered generating assets. OGE Energy Corp. was founded in 1902 and is headquartered in Oklahoma City, Oklahoma.Omeros NASDAQ:OMER$11.76 +0.06 (+0.53%) As of 12:45 PM Eastern This is a fair market value price provided by Massive. Learn more.Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases, including complement-mediated diseases, cancers, and addictive and compulsive disorders. The company's products under development include Narsoplimab (OMS721/MASP-2) that has completed pivotal trial for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); that is in Phase III clinical trial for the treatment of immunoglobulin A nephropathy (IgAN); and Phase II clinical trial to treat COVID-19. It also develops OMS1029 that is in phase I clinical trials for long-acting second-generation antibody targeting lectin pathway disorders; OMS906 that has completed phase II clinical trials for Paroxysmal nocturnal hemoglobinuria, complement 3 glomerulopathy, and other alternative pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders. In addition, the company's products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; and Adoptive T-Cell and Chimeric Antigen Receptor (CAR) T-Cell Therapies and Immunomodulators/Immunotoxins/Cancer Vaccines for the treatment of various cancers. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.uniQure NASDAQ:QURE$24.78 -0.15 (-0.61%) As of 12:45 PM Eastern This is a fair market value price provided by Massive. Learn more.uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease. In addition, it is developing AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands.Stardust Power NASDAQ:SDST$1.99 -0.12 (-5.69%) As of 12:42 PM Eastern This is a fair market value price provided by Massive. Learn more.Stardust Power Inc. is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nebius Group Pulls Back 9% After a Downgrade Despite Strong Earnings Rewiring AI: NextEra Energy Sparks a Mega Merger Flipping the Switch: Is Ford the Next Big Energy Stock? Does Nano Nuclear Energy’s New Deal Amp the Outlook? Dillard’s Posted a Huge Earnings Beat—So Why Did the Rally Fade? Why Trump’s Amazon Stock Sale May Not Matter at All Why Applied Optoelectronics Stock May Be Near a Turning Point Is Everspin Technologies the Next AI Edge Breakout? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
